TPE24 | Interview with Spree Bar: A “PMTA-exempt” Vape Product Targeting US Convenience Store

2Firsts Events by Charlotte Yu
Feb.02.2024
TPE24 | Interview with Spree Bar: A “PMTA-exempt” Vape Product Targeting US Convenience Store
Henry Sicignano, President of the U.S. electronic cigarette company Charlie's Holdings Inc., introduced the company's newly distributed product, the Spree Bar, during a pre-TPE forum.

On Jan 30 afternoon at the TPE Educational Sessions preceding the three-day exhibition, Henry Sicignano, the president of Charlie's Holdings Inc., delivered a keynote speech introducing their newly distributed product, Spree Bar, a disposable vaporization product with a capacity of 6000 puffs and a detachable, rechargeable battery, as well as nine flavors available. On Feb 1, the second day of the TPE trade show, 2FIRSTS had an exclusive interview with Henry on this novel product.

 

What sets Spree Bar apart is its active ingredient, a substance called Metatine, instead of Nicotine. Henry explained that Metatine is not the chemical name but a trademark of the substance, which is very much similar to " 6-methyl Nicotinamide".

 

TPE24 | Interview with Spree Bar: A “PMTA-exempt” Vape Product Targeting US Convenience Store
Concept of Metatine introduced at the TPE Educational Sessions | Source: 2FIRSTS

 

6-methyl Nicotinamide is an intermediate product in the synthesis of nicotine, according to an industry insider. Henry stated that they chose Metatine over 6-methyl nicotinamide because Metatine better brings the flavors coming along the e-liquid, providing consumers with a “nicotine vaping” experience.

 

As Metatine was still not subject to the regulatory scope of the FDA, the company took a decisive step to launch Spree Bar in last October. According to Henry, the product has achieved impressive sales results in the US, and they are preparing for a new marketing step in 2024 which will encompass around 15,000 convenience stores and supermarkets nationwide.

 

Henry presented a promotion flyer highlighting the characteristics of three currently available PMTA-approved products – VUSE, JUUL, and NJOY: tobacco flavor only, subject to tobacco tax, and relatively high prices. Being a "completely non-nicotine product," Metatine is neither synthesized nicotine nor a tobacco extract, making it for now still exempted from PMTA regulations and tobacco tax.

 

TPE24 | Interview with Spree Bar: A “PMTA-exempt” Vape Product Targeting US Convenience Store
Flyer highlighting differences between Spree Bar and other vape brands marketing in convenience stores | 2FIRSTS
TPE24 | Interview with Spree Bar: A “PMTA-exempt” Vape Product Targeting US Convenience Store
Nine available flavors provided by Spree Bar| Source: Official Store

 

The product has been selling legally with various flavors at lower prices in "virtually all 50 states*," as Henry explained. He described Metatine as "a market worth over a billion dollars."

 

(*Editor’s note: Flavor restrictions set by some US states target "flavored vapor products" rather than "flavored nicotine products." Spree Bar, as a vapor product, can not be marketed freely under the former condition.)

 

2FIRSTS found that their cartridge-only product is priced at $9.95 for retail, while a starter kit containing the battery, cartridge, and charging cable would cost around $20.

 

Henry mentioned that Spree Bar's product didn't undergo vivo toxicological testing before launch. However, he asserted that Metatine's toxicity must be lower than that of “oral nicotine” given the similarity between Metatine and nicotine. Additionally, the packaging includes a warning against use by pregnant women and prohibits sales to consumers under 21.

 

TPE24 | Interview with Spree Bar: A “PMTA-exempt” Vape Product Targeting US Convenience Store
Stylish promotion image with an artistic portrait on it. | Source: Official Store

 

In terms of user experience, Henry stated that Spree Bar's product is "indistinguishable from nicotine e-cigarettes," facilitating the transition for e-cigarette consumers.

 

When asked if he's concerned about competitors introducing similar products to carve up their market share, Henry remains optimistic about Spree Bar's market prospects, believing that their over-a-year-long preparation before launch has likely secured a strong position in major Key Account channels before competitors could make similar moves.

 

Some Chinese e-liquid manufacturers are exploring this technology, while due to concerns about public opinion and regulatory risks, relevant products have not yet been introduced to the market, according to an insider.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
Key provisions of the UK's Tobacco and Vapes Act 2026 will take effect on Oct. 29, extending an age-18 sales restriction to all vaping and non-medicinal nicotine products. In England, Wales and Northern Ireland, the change brings zero-nicotine vapes within statutory age-of-sale rules and also covers products including nicotine pouches, strips and pearls. The law will also prohibit proxy purchasing for under-18s, consumer-facing vending machines, promotional giveaways and substantial discounts intended to promote vaping and nicotine products.
Regulations
Oct.10
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08